NEWHALL CHARLES W III

10% owner at INTERCELL USA, INC. · on record since Jan 25, 2006
10% owner at ARYx Therapeutics, Inc. · on record since Nov 14, 2008
10% owner at VONAGE HOLDINGS CORP · on record since May 23, 2006
10% owner at GYRE THERAPEUTICS, INC. · on record since Apr 20, 2006
10% owner at Paratek Pharmaceuticals, Inc. · on record since May 17, 2006
10% owner at OCCAM NETWORKS INC/DE · on record since Apr 7, 2006
10% owner at INNERWORKINGS INC · on record since Aug 15, 2006
Director at PHARMOS CORP · on record since Oct 27, 2006
10% owner at HEMOSENSE INC · on record since Dec 21, 2006
Former 10% Owner at OCCAM NETWORKS INC/DE · on record since Nov 9, 2006
10% owner at AMICUS THERAPEUTICS, INC. · on record since May 30, 2007
10% owner at GLU MOBILE INC · on record since Mar 27, 2007
10% owner at FIREPOND INC · on record since Mar 15, 2007
10% owner at DZS INC. · on record since Mar 7, 2007
10% owner at Data Domain, Inc. · on record since Jun 26, 2007
10% owner at Inteliquent, Inc. · on record since Nov 9, 2007
10% owner at PEPLIN INC · on record since Oct 30, 2008
10% owner at PHARMOS CORP · on record since Apr 23, 2009
10% owner at · on record since Apr 6, 2009
10% owner at · on record since Oct 30, 2009
Former 10% owner at · on record since Dec 29, 2005
10% owner at · on record since Mar 23, 2010
10% owner at · on record since Jun 23, 2010
10% owner at · on record since Jun 16, 2011
10% owner at · on record since May 3, 2011
10% owner at · on record since Nov 3, 2011
10% owner at · on record since Oct 22, 2003
10% owner at · on record since Oct 29, 2003
10% owner at · on record since Nov 5, 2003
Director at · on record since Apr 30, 2012
10% owner at · on record since Apr 30, 2012
10% owner at · on record since May 16, 2012
10% owner at · on record since Nov 18, 2003
10% owner at · on record since Jul 25, 2012
10% owner at · on record since Oct 18, 2012
10% owner at · on record since Dec 16, 2003
10% owner at · on record since Jan 22, 2004
Director at · on record since Sep 26, 2014
10% owner at · on record since Sep 20, 2005
Former 10% Owner at · on record since Sep 30, 2004
10% owner at · on record since Oct 26, 2004
Former 10% Owner at · on record since Nov 4, 2004
Former 10% Owner at · on record since Nov 4, 2005
10% owner at · on record since Oct 1, 2009

Insider trading activity of NEWHALL CHARLES W III

Transactions on record: 552; since Oct 22, 2003

Open-market buys: 247; $106.5M

Open-market sells: 47; $60.6M

Companies traded: 27; last filing Feb 25, 2026

Figures computed from official regulatory filings — .

Companies where NEWHALL CHARLES W III has traded

54 tx · $24.6M · Feb 25, 2026
4 tx · Jul 10, 2015
2 tx · Oct 18, 2012
40 tx · $41M · Sep 6, 2012
24 tx · $6M · Aug 2, 2012
18 tx · $1.9M · Jul 3, 2012
20 tx · $12.6M · Mar 30, 2012
12 tx · $7M · Mar 9, 2012
4 tx · Mar 1, 2012
19 tx · $280.5M · Feb 15, 2012
4 tx · $1.3M · Aug 9, 2011
16 tx · Mar 15, 2011
13 tx · Sep 1, 2010
6 tx · $7.5M · Feb 3, 2009
1 tx · Aug 20, 2008

Track record of NEWHALL CHARLES W III

Statistical track record

Free account

Open-market buys: 255

Last buy: Jul 31, 2012

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of NEWHALL CHARLES W III

Co-insiders of NEWHALL CHARLES W III

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 25, 2026	OtherD (derivative)	-4,475	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 25, 2026	Award	4,475	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 20, 2026	AwardD (derivative)	2,989	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 20, 2026	AwardD (derivative)	4,977	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 24, 2025	Exercise	15,000	12.98 USD	$194.7K	Unusual size	SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 24, 2025	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Oct 10, 2025	Sell	-23,800	50.73 USD	$1.2M		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Oct 10, 2025	Sell	-1,200	51.55 USD	$61.9K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Aug 29, 2025	Sell	-3,588	45.01 USD	$161.5K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Aug 27, 2025	Sell	-1,000	45.00 USD	$45K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Aug 26, 2025	Sell	-1,412	45.00 USD	$63.5K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 24, 2025	Award	5,369	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 24, 2025	OtherD (derivative)	-5,369	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 21, 2025	AwardD (derivative)	7,296	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 21, 2025	AwardD (derivative)	4,475	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 12, 2024	Sell	-10,700	36.24 USD	$387.8K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 12, 2024	ExerciseD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 12, 2024	Exercise	20,000	9.13 USD	$182.6K	Unusual size	SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 27, 2024	Award	3,886	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 27, 2024	OtherD (derivative)	-3,886	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 26, 2024	AwardD (derivative)	5,369	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 26, 2024	AwardD (derivative)	8,252	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 20, 2023	ExerciseD (derivative)	-7,457	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 20, 2023	Exercise	7,457	9.24 USD	$68.9K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 20, 2023	Sell	-2,500	28.01 USD	$70K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 25, 2026	OtherD (derivative)	-4,475	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 25, 2026	Award	4,475	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 20, 2026	AwardD (derivative)	2,989	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 20, 2026	AwardD (derivative)	4,977	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 24, 2025	Exercise	15,000	12.98 USD	$194.7K	Unusual size	SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 24, 2025	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Oct 10, 2025	Sell	-23,800	50.73 USD	$1.2M		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Oct 10, 2025	Sell	-1,200	51.55 USD	$61.9K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Aug 29, 2025	Sell	-3,588	45.01 USD	$161.5K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Aug 27, 2025	Sell	-1,000	45.00 USD	$45K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Aug 26, 2025	Sell	-1,412	45.00 USD	$63.5K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 24, 2025	Award	5,369	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 24, 2025	OtherD (derivative)	-5,369	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 21, 2025	AwardD (derivative)	7,296	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 21, 2025	AwardD (derivative)	4,475	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 12, 2024	Sell	-10,700	36.24 USD	$387.8K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 12, 2024	ExerciseD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 12, 2024	Exercise	20,000	9.13 USD	$182.6K	Unusual size	SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 27, 2024	Award	3,886	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 27, 2024	OtherD (derivative)	-3,886	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 26, 2024	AwardD (derivative)	5,369	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Feb 26, 2024	AwardD (derivative)	8,252	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 20, 2023	ExerciseD (derivative)	-7,457	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 20, 2023	Exercise	7,457	9.24 USD	$68.9K		SEC
SUPERNUS PHARMACEUTICALS, INC.Listing on record	Nov 20, 2023	Sell	-2,500	28.01 USD	$70K		SEC